Cargando…
Correction to: Calycosin inhibits the in vitro and in vivo growth of breast cancer cells through WDR7-7-GPR30 Signaling
Autores principales: | Tian, Jing, Wang, Yong, Zhang, Xing, Ren, Qianyao, Li, Rong, Huang, Yue, Lu, Huiling, Chen, Jian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6389106/ https://www.ncbi.nlm.nih.gov/pubmed/29298702 http://dx.doi.org/10.1186/s13046-017-0660-8 |
Ejemplares similares
-
Calycosin inhibits the in vitro and in vivo growth of breast cancer cells through WDR7-7-GPR30 Signaling
por: Tian, Jing, et al.
Publicado: (2017) -
Correction for: Calycosin stimulates the proliferation of endothelial cells, but not breast cancer cells, via a feedback loop involving RP11-65M17.3, BRIP1 and ERα
por: Wang, Yong, et al.
Publicado: (2022) -
Calycosin stimulates the proliferation of endothelial cells, but not breast cancer cells, via a feedback loop involving RP11-65M17.3, BRIP1 and ERα
por: Wang, Yong, et al.
Publicado: (2021) -
Calycosin-7-O-β-d-glucoside attenuates ischemia-reperfusion injury in vivo via activation of the PI3K/Akt pathway
por: REN, MIN, et al.
Publicado: (2016) -
In vivo Effects of a GPR30 Antagonist
por: Dennis, Megan K., et al.
Publicado: (2009)